Group 1 - Dollar General Corporation (NYSE:DG) is perceived as a strong player in the discount retail sector, benefiting from a cash-strapped consumer base and countercyclical business model [1][2] - The company has successfully reduced its direct imports from China to less than 70% and indirect imports to less than 40%, although it still faces challenges from tariffs [1] - Dollar General's stock has increased over 50% year to date, indicating strong performance despite previous execution issues and rising competition [2] Group 2 - The company is making progress in addressing operational challenges, including store standards, supply-chain execution, and labor efficiency [2] - With inflation stabilizing, there are signs of increased customer activity, as basket sizes and units are beginning to rise again [2] - The potential for Dollar General to benefit from trade-down business during economic downturns positions it favorably in the current market environment [2]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Gauzy Ltd. due to allegations of violations of federal securities laws, with a deadline for investors to seek lead plaintiff status by February 6, 2026 [1][3]. Summary by Sections Allegations Against Gauzy Ltd. - The complaint alleges that Gauzy Ltd. and its executives made false and misleading statements and failed to disclose critical financial issues regarding three French subsidiaries, which lacked the means to meet their debts [3]. - It is claimed that these subsidiaries were likely to face insolvency proceedings, which could trigger defaults under the company's senior secured debt facilities [3]. Market Reaction - On November 14, 2025, Gauzy Ltd. announced the commencement of French insolvency proceedings against its subsidiaries, leading to a significant drop in share price [4]. - The company's stock fell by $2.00 per share, nearly 50%, closing at $2.02 on November 17, 2025, amid unusually heavy trading volume [5]. Legal Proceedings - The lead plaintiff in the class action will be the investor with the largest financial interest who can adequately represent the class [6]. - Faruqi & Faruqi encourages individuals with information regarding Gauzy's conduct to come forward, including whistleblowers and former employees [7].

Ondas Holdings Inc. (NASDAQ:ONDS) is one of the stocks Jim Cramer shed light on. Toward the end of the lightning round, a caller asked about the stock, and Cramer replied: “I mean, that thing is just a, look, I view that as a cats and dog thing, to be honest. I cannot, wow, that one is a really complicated stock… I’m going to have to take a pass.” Source: Ondas Holdings Inc. Press Release Ondas Holdings Inc. (NASDAQ:ONDS) provides wireless communication and drone solutions, including AI-powered drones ...

M&T Bank Corporation (NYSE:MTB) is one of the stocks Jim Cramer shed light on. When a caller inquired about the stock during the lightning round, Cramer said: “Very well-run bank. It’s still not that expensive. Actually, it’s surprisingly inexpensive. I would buy that stock tomorrow morning, even though it looks like it’s going to spike. It’s at 12 times earnings. There’s nothing not to like about M&T Bank. It’s good.” Stock market data showing an upward trajectory. Photo by Burak The Weekender on Pexe ...

Diageo plc (NYSE:DEO) is one of the stocks Jim Cramer shed light on. Inquiring about the stock, a caller noted that the company might have a “new CEO turnaround story.” Here’s what Mad Money’s host had to say in response: “Okay, let me give you my, I think that the dividend at 5.6 can keep it here. They have to come up with something very special because I see a lot of their lines of business not doing well. Okay, I’m going to throw in Constellation and Brown-Forman, downgraded again, too. I don’t own sto ...

Daktronics, Inc. (NASDAQ:DAKT) is one of the stocks Jim Cramer shed light on. Asking if the stock is a buy, sell, or hold, a caller highlighted that the company has a new CEO and is institutionally held by BlackRock and others. In response, Cramer said: “You know, it’s just okay. I’ve never been excited about that scoreboard business, advertising, it’s just not compelling enough to put your money into.” A stock market graph. Photo by energepic.com Daktronics, Inc. (NASDAQ:DAKT) manufactures electronic ...

Lithium Americas Corp. (NYSE:LAC) is one of the stocks Jim Cramer shed light on. When a caller asked about the stock during the lightning round, Cramer stated: “No, no, there’s nothing there for you. We’re just going to have to skip it. That’s a yesteryear stock. It’s just, it’s a no-go.” Photo by Adam Nowakowski on Unsplash Lithium Americas Corp. (NYSE:LAC) operates lithium deposits and processing facilities, with its main project at Thacker Pass. It is worth noting that the stock is up over 50% year ...

Rocket Lab Corporation (NASDAQ:RKLB) is one of the stocks Jim Cramer shed light on. A caller asked if Cramer would include the stock “in the end of the year of magical investing,” and he commented: “I think Rocket Lab’s better than that. I don’t think it’s a magical thinking… I think it’s a very good spec ahead of another big offering in the rocket world next year. I think you can own it as your spec play, as I say in How to Make Money in Any Market.” Pixabay/Public Domain Rocket Lab Corporation (NASD ...

Elanco Animal Health Incorporated (NYSE:ELAN) is one of the stocks Jim Cramer shed light on. Answering a caller’s query about the stock, Cramer said: “They are doing everything right. I am so impressed with the way they’ve turned that company around. I’m glad you brought it out. That was a real good idea.” A laptop and a computer monitor display a detailed stock market technical analysis chart. Photo by Jakub Zerdzicki on Pexels Elanco Animal Health Incorporated (NYSE:ELAN) sells products to protect a ...

Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer shed light on. During the lightning round, a caller sought Cramer’s opinion on the stock, and he said: “Okay, Pfizer, really good yield, not a lot of momentum. Didn’t like the update yesterday. I’m going to say just weak hold.” Photo by Spencer Davis on Unsplash Pfizer Inc. (NYSE:PFE) creates and sells medicines and vaccines for several health conditions, including heart disease, infections, COVID-19, and rare diseases. Cramer was asked about the ...